[Federal Register Volume 89, Number 155 (Monday, August 12, 2024)]
[Notices]
[Page 65635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-17793]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2024-N-1532]


Agency Information Collection Activities; Proposed Collection; 
Risk/Safety Considerations and Motivations for Purchase and Use of 
Kratom and Psychedelics Alone and in Combination With Other Substances; 
Withdrawal of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; withdrawal.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
withdrawal of a notice that was published in the Federal Register of 
August 2, 2024.

DATES: The notice is withdrawn on August 12, 2024.

FOR FURTHER INFORMATION CONTACT: Darren Eicken, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 51, Rm. 6206, Silver Spring, MD 20993-0002, 240-
402-0978.

SUPPLEMENTARY INFORMATION: In a notice published in the Federal 
Register of August 2, 2024 (89 FR 63202), ``Agency Information 
Collection Activities; Proposed Collection; Comment Request: Risk/
Safety Considerations and Motivations for Purchase and Use of Kratom 
and Psychedelics Alone and in Combination With Other Substances,'' FDA 
requested comment on the information collection associated with the 
proposed study entitled ``Risk/Safety Considerations and Motivations 
for Purchase and Use of Kratom and Psychedelics Alone and in 
Combination With Other Substances.''
    Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies 
are required to publish notice in the Federal Register concerning each 
proposed collection of information, including each proposed extension 
of an existing collection of information, and to allow 60 days for 
public comment in response to the notice.
    In the August 2, 2024, Federal Register notice, FDA proposed a new 
collection of information. However, FDA no longer intends to proceed 
with the proposed study as described because circumstances occurred 
necessitating changes to the scope of the study. Therefore, we are 
withdrawing the August 2, 2024, notice.

    Dated: August 6, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-17793 Filed 8-9-24; 8:45 am]
BILLING CODE 4164-01-P